Evidence database

Best practice portal main page

Pharmacological treatments for personality and substance use disorders

Summary of the evidence

Rating
  • Unknown effectiveness

A comprehensive review (EMCDDA 2015) found that:

  • there is no evidence that any pharmacotherapy is particularly beneficial in the comorbidity of personality disorders with substance use disorders

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option
  • Integrated co-morbidity treatment
Desired outcome(s)
  • improve mental health outcomes
  • reduce substance use
Area(s)
  • Treatment
Specific substance or pattern of use
  • co-morbidity
Target group(s) or setting(s)
  • dual-diagnosis patients

References

Explore all resources in the Best practice portal

 

Miniguides

A one-stop-shop for anyone planning or delivering health and social responses.

 

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

 

Evidence

All of the latest research and evidence on drug-related interventions.

 

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

About the Best practice portal

Collaborations and partnerships in best practice

Logo of the Cochrane Collaboration
Logo of the Campbell Collaboration
Grade logo
WHO logo
Top